Monoclonal gammopathy of undetermined significance surgery: Difference between revisions
Created page with "__NOTOC__ {{ Monoclonal gammopathy of undetermined significance }} Please help WikiDoc by adding content here. It's easy! Click here to learn a..." |
Shyam Patel (talk | contribs) No edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ Monoclonal gammopathy of undetermined significance }} | {{Monoclonal gammopathy of undetermined significance }} | ||
{{CMG}}; {{AE}} {{OK}} | |||
==Overview== | |||
Surgery is not the first-line treatment option for patients with MGUS. Surgery is usually reserved for patients with skeletal fractures. Procedures like kyphoplasty and vertebroplasty are usually performed for vertebral fractures. | |||
== Surgery == | |||
Surgery is not the first-line treatment option for patients with MGUS. Surgery is usually reserved for patients with skeletal fractures. Procedures like kyphoplasty and vertebroplasty are usually performed for vertebral fractures.<ref name="pmid20507313">{{cite journal |vauthors=Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA |title=Monoclonal gammopathy of undetermined significance: a consensus statement |journal=Br. J. Haematol. |volume=150 |issue=1 |pages=28–38 |date=July 2010 |pmid=20507313 |doi=10.1111/j.1365-2141.2010.08207.x |url=}}</ref> Surgery is usually reserved for patients with skeletal fractures<ref name="pmid205073132">{{cite journal |vauthors=Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA |title=Monoclonal gammopathy of undetermined significance: a consensus statement |journal=Br. J. Haematol. |volume=150 |issue=1 |pages=28–38 |date=July 2010 |pmid=20507313 |doi=10.1111/j.1365-2141.2010.08207.x |url=}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 03:56, 3 January 2019
|
Monoclonal gammopathy of undetermined significance Microchapters |
|
Differentiating Monoclonal gammopathy of undetermined significance from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Monoclonal gammopathy of undetermined significance surgery On the Web |
|
American Roentgen Ray Society Images of Monoclonal gammopathy of undetermined significance surgery |
|
FDA on Monoclonal gammopathy of undetermined significance surgery |
|
on Monoclonal gammopathy of undetermined significance surgery |
|
Monoclonal gammopathy of undetermined significance surgery in the news |
|
Blogs on Monoclonal gammopathy of undetermined significance surgery |
|
Directions to Hospitals Treating Monoclonal gammopathy of undetermined significance |
|
Risk calculators and risk factors for Monoclonal gammopathy of undetermined significance surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
Surgery is not the first-line treatment option for patients with MGUS. Surgery is usually reserved for patients with skeletal fractures. Procedures like kyphoplasty and vertebroplasty are usually performed for vertebral fractures.
Surgery
Surgery is not the first-line treatment option for patients with MGUS. Surgery is usually reserved for patients with skeletal fractures. Procedures like kyphoplasty and vertebroplasty are usually performed for vertebral fractures.[1] Surgery is usually reserved for patients with skeletal fractures[2]
References
- ↑ Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA (July 2010). "Monoclonal gammopathy of undetermined significance: a consensus statement". Br. J. Haematol. 150 (1): 28–38. doi:10.1111/j.1365-2141.2010.08207.x. PMID 20507313.
- ↑ Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA (July 2010). "Monoclonal gammopathy of undetermined significance: a consensus statement". Br. J. Haematol. 150 (1): 28–38. doi:10.1111/j.1365-2141.2010.08207.x. PMID 20507313.